Medifast (NYSE: MED) reported Q3 EPS of $2.12, $1.05 better than the analyst estimate of $1.07. Revenue for the quarter came in at $235.9 million versus the consensus estimate of $232.1 million.

For earnings history and earnings-related data on Medifast (MED) click here.